Nabla Bio
We use AI to design antibodies for intractable diseases
About
Our mission is to enable pharmaceutical and biotech companies to bring more antibody therapies to patients. Using AI and massively parallel experimentation, we design antibodies that precisely bind the disease target at the right location, while minimizing manufacturability and toxicity risks. We are a well-funded, revenue-generating, bilingual company of wet- and dry-lab scientists, and are founded by AI and protein design experts from Harvard University.
Topics
- Location
- Boston, MA, United States
- Team size
- 8 employees
- YC batch
- Summer 2020
- Status
- Active
- Stage
- Growth stage
